On the other hand, carriers of BRCA2 PGVs display: (i) an absolute risk of BC higher than 60%; (ii) an absolute risk of male BC ranging from 1.8 to 7.1%; and (iii) an absolute risk of epithelial ovarian cancer ranging from 13 to 29% [5,11,12]. This evidence concerns the gene BRCA2 and ovarian carcinoma.